Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...

Merck & Co – known as MSD outside of the US and Canada – has unveiled a new cost-cutting plan aimed at saving $3bn every year by the end of 2027. The annual cost savings generated by the “multi-year ...

Every year, ASCO arrives with a theme. Most quietly disappear into the background by the end of the opening session, overtaken by survival curves, late-breaking data and the relentless pace of ...

Klick Health, a global, independent commercialisation partner for life sciences, has acquired Oxford PharmaGenesis, a ...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Novartis is set to acquire Myricx Bio, paying $1.1bn upfront, with up to $400m in potential milestone payments. The acquisition would strengthen Novartis’ oncology pipeline and advance next-generation ...

Women in Healthcare Leadership podcast series. Now on its fourth series, “Hear from Her” has established itself globally as ...

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and ...

In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’ ...